Abstract
IVIG is the definitive therapy for primary immunodeficiency diseases associated with hypogammaglobulinemia or specific antibody deficiencies. Administration of IVIG is relatively safe, but occasional adverse reactions are usually self-limited and generally are not an indication for stopping therapy. Home administration of IVIG has found increasing favor among treating physicians and their patients
Similar content being viewed by others
References
Cohn, E. J., Oncley, J. L., Strong, L. E., Hughes, W. L., Jr., and Armstrong, S. H., Jr. (1944),J. Clin. Invest. 23, 417–432.
Dwyer, J. M. (1984),Am. J. Med. 76 (3A), 46–52.
Prophylactic gamma globulin for prevention of endemic hepatitis. Effects of US gamma globulin upon the incidence of viral hepatitis and other infectious diseases in US soldiers abroad. (1971),Arch. Intern. Med. 128, P723–738.
Bruton, O. (1952),Pediatrics 9, 722–728.
Miller, M. E. (1973),J. Allergy Clin. Immunol. 51, 45–56.
Pirofsky, B., Campbell, S. M., and Montanaro, A. (1982),J. Clin. Immunol. 2 (2 Suppl.), 7S-14S.
Imbach, P., Barandun, S., d’Apuzzo, V., Baumgartner, C., Hirt, A., Morell, A., Rossi, E., Schoni, M., Vest, M., and Wagner, H. P. (1981),Lancet 1, 1228–1231.
Bussel, J. B., Kimberly, R. P., Inman, R. D., Schulman, I., Cuningham-Rundles, C., Cheung, N., Smithwick, E. M., O’Malley, J., Barandun, S., and Hilgartner, M. W. (1983),Blood 62, 480–486.
Besa, E. C. (1984),Am. J. Med. 76 (3A), 209–218.
Cooperative Group for the Study of Immunoglobulin in Chronic Lymphoctyic Leukemia (1988),N. Engl. J. Med. 319, 902–907.
Ballow, M., Levinson, A. I., Gelfand, E., and Schwartz, S. A. (eds.) (1990),J. Clin. Immunol. 10, (Suppl.) 1s–96s.
Gronski, P., Kanzy, E. J., Ronneberger, H. J., Geursen, R., and Seiler, F. R. (1987),Dev. Biol. Stand. 67, 239–256.
Lundblad, J. L. and Londeree, N. (1988),J. Hosp. Infect. 12 (Suppl. D), 3–15.
Rousell, R. H. (1988),J. Hosp. Infect. 12 (Suppl. D), 17–27.
Rousell, R. H., Good, R. A., Pirofsky, B., and Schiff, R. (1988),Vox Sang 54, 6–13.
Uemura, Y., Yokoyama, K., Nishida, M., and Suyama, T. (1989),Vox Sang 57, 1–3.
NIH Consensus Conference (1990),JAMA 264, 3189–3193.
Buyse, M. L. (ed.) (1990),Birth Defects Encyclopedia. Blackwell Scientific, Cambridge, MA.
Nolte, M. T., Pirofsky, B., Gerritz, G. A., and Golding, B. (1979),Clin. Exp. Immunol. 36, 237–243.
Kobayashi, N., Gohya, N., and Matsumoto, S. (1981),Eur. J. Pediatr. 136, 159–165.
Ammann, A. J., Ashman, R. F., Cubkley, R. H., Hardie, W. R., Krantmann, H. J., Nelson, J., Qchs, H., Stiehm, E. R., Tiller, T., Wara, D. W., and Wedgwood, R. (1982),Clin. Immunol. Immunopathol. 22, 60–67.
Buckley, R. H. (1982),J. Clin. Immunol. 2 (2 Suppl.), 15S-21S.
Eibl, M. M., Cairns, L., and Rosen, F. S. (1984),Clin. Immunol. Immunopathol. 31, 151–160.
So, A., Brenner, M. K., Hill, I. D., Asherson, G. L., and Webster, A. D. (1984),Br. Med. J. [Clin. Res.] 289, 1177–1178.
Bender, S. and Hetherington, S. (1987),J. Clin. Immunol. 7, 475–480.
Rossipal, E. (1978),Wien Med. Wochenschr. 128, 240–243.
Lederman, H. M. and Winkelstein, J. A. (1985),Medicine 64, 145–156.
Ochs, H. D., Lee, M. L., Fischer, S. H., Delson, E. S., Chang, B. S., and Wedgwood, R. J. (1987),J. Infect. Dis. 156, 652–654.
Ryan, A., Thomson, B. J., and Webster, A. D. (1988),Lancet 2, 793.
Kobayashi, R. H., Kobayashi, A. D., Lee, N., Fischer, S., and Ochs, H. D. (1990),Pediatrics 85, 705–709.
Roberton, D. M., Hosking, C. S., Efthimious, H., Wright, S., Upton, H., Colgan, T., Hartman, L., and Schiff, P. (1987),Aust. NZ J. Med. 17, 495–500.
Roberton, D. M. and Hosking, C. S. (1988),Aust. Paediatr. J. 24, 174–177.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schwartz, S.A. Clinical use of immune serum globulin as replacement therapy in patients with primary immunodeficiency syndromes. Clinical Reviews in Allergy 10, 1–12 (1992). https://doi.org/10.1007/BF02914366
Issue Date:
DOI: https://doi.org/10.1007/BF02914366